The Hodgkin lymphoma survival rate is encouraging, especially when this relatively rare type of cancer is diagnosed and treated in its earliest stages. As research progresses and the scientific knowledge base grows, new and better treatment options are continually being developed, further improving the prognoses for many patients. In fact, a complete cure is possible in some cases.
The overall Hodgkin lymphoma survival rate is determined based on data from numerous patients who had the condition in the past. Even though no two patients are exactly alike, this information can provide helpful guidance for a physician when evaluating treatment options for a patient, particularly when viewed within the context of the patient’s unique circumstances. For instance, several factors that can influence a patient’s outcome but are unaccounted for in the overall Hodgkin lymphoma survival rate include a patient’s:
- Hodgkin lymphoma stage at the time of diagnosis
- Blood albumin level (a protein)
- Hemoglobin level (an oxygen-carrying component of red blood cells)
- Overall white blood cell count
- Lymphocyte count (white blood cells in the lymphatic system)
- Overall health condition
At Moffitt Cancer Center, the multispecialty team in our Malignant Hematology Program considers the overall survival rate as well as multiple factors that are unique to a patient to determine the patient’s individual prognosis and develop a comprehensive treatment plan. Generally, the most important consideration in the choice of treatment is the extent of the cancer’s spread throughout the body (the stage of the lymphoma). Moffitt offers the latest treatment options for all types and stages of lymphoma; additionally, through our robust clinical trial program, our patients have access to promising new therapies that are not yet available in other settings.
To schedule a consultation with the cancer experts at Moffitt, call 1-888-663-3488 or submit a new patient registration form online. Our team can provide you with more detailed information regarding the Hodgkin lymphoma survival rate, as well as steps you can take to improve your own prognosis.